Predictors of Early and Late Response to Esomezol and Lifestyle Modification in Adults With Laryngopharyngeal Reflux Disease: A Prospective, Multicenter, Open-Label Cohort Study.

"This study was partially supported by a research grant from Hanmi Pharmaceutical Co. Ltd. (research ID: HM-IIT-ESO-004). This was an investigator-initiated study, and the funding company had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. No other potential conflicts of interest relevant to this article were reported."

"This study was partially supported by a research grant from Hanmi Pharmaceutical Co. Ltd. (research ID: HM-IIT-ESO-004). This study was partially supported by a research grant from Hanmi Pharmaceutical Co. Ltd. (research ID: HM-IIT-ESO-004). This was an investigator-initiated study, and the funding company had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. No other potential conflicts of interest relevant to this article were reported. AUTHOR CONTRIBUTIONS: Conceptualization: all authors. Methodology: SKK, EJJ, JHS, DIS, SMJ, BJL, ISP, JGC, YHP. Software: SKK, SJP, YHP. Validation: all authors. Investigation: SKK, EJJ, JHS, DIS, SMJ, BJL, ISP, JGC, YHP. Formal analysis: SKK, SJP, YHP. Data curation: SKK, SJP. Project administration: SKK, YHP. Funding acquisition: SKK, YHP. Writing–original draft: SKK, SJP, YHP. Writing–review & editing: all authors."